| First Author | Edwards W | Year | 2023 |
| Journal | Development | Volume | 150 |
| Issue | 21 | PubMed ID | 37756602 |
| Mgi Jnum | J:342149 | Mgi Id | MGI:7545601 |
| Doi | 10.1242/dev.201677 | Citation | Edwards W, et al. (2023) The Tbx20-TLE interaction is essential for the maintenance of the second heart field. Development 150(21):dev201677 |
| abstractText | T-box transcription factor 20 (Tbx20) plays a multifaceted role in cardiac morphogenesis and controls a broad gene regulatory network. However, the mechanism by which Tbx20 activates and represses target genes in a tissue-specific and temporal manner remains unclear. Studies show that Tbx20 directly interacts with the Transducin-like Enhancer of Split (TLE) family of proteins to mediate transcriptional repression. However, a function for the Tbx20-TLE transcriptional repression complex during heart development has yet to be established. We created a mouse model with a two amino acid substitution in the Tbx20 EH1 domain, thereby disrupting the Tbx20-TLE interaction. Disruption of this interaction impaired crucial morphogenic events, including cardiac looping and chamber formation. Transcriptional profiling of Tbx20EH1Mut hearts and analysis of putative direct targets revealed misexpression of the retinoic acid pathway and cardiac progenitor genes. Further, we show that altered cardiac progenitor development and function contribute to the severe cardiac defects in our model. Our studies indicate that TLE-mediated repression is a primary mechanism by which Tbx20 controls gene expression. |
